Postdoctoral Fellows from any country and all disciplines can apply.
Registration Now Open.
Applications Due March 20, 2019
The ALS Association Research MILTON SAFENOWITZ POSTDOCTORAL FELLOWSHIP GRANT PROGRAM supports INNOVATIVE research of high scientific merit and relevance to ALS.
The ALS Association Global Research Program leads the scientific community in finding effective treatments and cure for ALS, and a better life for people with ALS, their caregivers, and families. The Association is the largest private funder of ALS research worldwide, and our efforts have led to some of the most promising and significant advances in ALS research.
The ALS Association, as a funder in a disease without a cure, believes that the more researchers collaborate and share information, the faster they will arrive at effective treatments and a cure. With this in mind, the Association encourages open access publications, pre-registered protocols, and open data sharing whenever possible. The Association also values collaboration whenever possible to encourage partnerships to prevent duplication and promote innovation. Both open sharing and collaboration will be positively evaluated in submitted applications.
The ALS Association is proud to support the development of new scientists through the Milton Safenowitz Postdoctoral Fellowship. The Safenowitz family, through The Greater New York Chapter of The ALS Association, founded the award in memory of Mr. Safenowitz, who died of ALS in 1998. These awards are to encourage and facilitate promising young scientists to enter the ALS field. Fellows work with a senior mentor and receive extensive exposure to the ALS research community through meetings and presentations. After completing this fellowship, approximately 76 percent of the awardees stay in ALS research. They go on to establish their own laboratories to continue studying ALS and mentor more ALS researchers along the way. Other postdoctoral fellows have moved on to successful careers in industry, medical writing, and non-profit.
Collaboration is highly encouraged between awarded fellows. To foster this collaborative environment, The Greater New York Chapter of the ALS Association sponsors the Milton Safenowitz Postdoctoral Fellowship Symposium in New York, N.Y.. Bi-annually, the fellows gather to share research ideas through short presentations covering their research projects and are joined by the Safenowitz family for an awards ceremony.
Topics of interest
In this call for applications – we look to fund the most promising new scientists that will improve our understanding of ALS and/or lead to ways to cure ALS, reduce symptoms or prevent their expression, or improve the lives of those impacted by this disease. We will accept applications from all scientific disciplines.
This is a general call for all potential postdoctoral fellows with topics of study related to ALS. We are especially interested in Fellowships supporting:
- Biomarkers studies to discover and validate ALS biomarkers that can facilitate clinical trials, demonstrate biological effect of promising therapeutics, and speed diagnosis.
- Clinical trial methodology, including ways to increase trial participation, reduce burden and risk for participation, and increase speed and effectiveness.
- Studies of or methods for drug target identification including animal models, cell models, methods for high throughput screening, etc.
- Studies that could ultimately stop ALS progression before impairment, including methods for detection and identification of potential therapeutic options.
- Studies that could ultimately reduce the risk of developing ALS for people with genetic risk factors, including studies of epigenetics, gene-environment interactions, and associated methodologies.
- Research infrastructure, such as existing ALS repositories and consortia. Fellowships focused on developing new infrastructure must explain how their project complements new infrastructure.
- Drug development: Preclinical assessment of therapeutics for ALS pre-IND with a likely chance of reaching the clinic within 3 years.
- Clinical Trials: Fellowships supporting clinical trials, including Phase I through Phase IV.
- Studies to help people live with ALS, including:
- Assistive technology: The development of new technology can improve the quality of life for people with ALS and their families to live a more meaningful and productive life.
- Caregiver and family burden: Fellowships that will document and relieve the impacts of ALS on caregivers and families of people with ALS.
- Any other proposal with the chance of significantly improving our understanding of ALS or improving the lives of those impacted.
The Milton Safenowitz Postdoctoral Fellowship Program Awards
The maximum amount awarded is $50,000 (US) per year for 2 years. Eligibility is limited to those who have an existing postdoctoral fellowship and the support of their mentor. Any researcher from any country can apply. Applicants who have been fellows for more than two years by the time their fellowship starts are ineligible.
Applicants will submit a full application that will be screened for applicability by staff, and if eligible, reviewed by external experts. Letters of intent are not required and are not accepted for the Postdoctoral Fellowship Program.
Step 1: Register using this link:
Step 2: Login using this link:
Step 3: Complete online application using this link:
Application Due: March 20, 2019
Application Review Decision: May 2019
Grant Agreement Sent: June 2019
Funding Commences: As early as July 2019